@FierceMedDev: Work advances on early-detection ovarian cancer blood Dx. Story | Follow @FierceMedDev
@MarkHFierce: J&J faces possible punitive damages in the first verdict regarding faulty vaginal mesh. Thousands of cases to come. Report | Follow @MarkHFierce
@DamianFierce: The device industry is urging lawmakers to settle on a budget and, of course, repeal the device tax. Article | Follow @DamianFierce
> A witness for Johnson & Johnson ($JNJ) testified that infection rather than a defect forced a patient to have replacement surgery for his ASR metal-on-metal hip. Story
> Boston Scientific ($BSX) is seeking zoning changes to accommodate plans to move its corporate headquarters to Marlborough, MA. Story
> The FDA slapped Woo Young Medical in South Korea with a warning letter, citing the company for quality system violations regarding the manufacturing of its elastomeric infusion pumps. Letter
> The Arizona Heart Foundation is sponsoring U.S clinical trials for a multilayer flow modulator stent made by Cardiatis in Belgium. Story
> With breast cancer cases on the rise, Frost & Sullivan predicts a modest growth in demand for breast-imaging equipment. Item
> Philips is mulling a name change to better reflect the company's diverse business lines, which range from healthcare to lighting and consumer health. Story
> Tandem Diabetes Care won FDA clearance for its t:connect diabetes-management program, a web-based data management system for its t:slim insulin pump. Release
Biotech News
@FierceBiotech: From FierceVaccines.com: Is it too soon to quit on Nabi's nicotine vaccine? More | Follow @FierceBiotech
@JohnCFierce: Optimer shares spiking with CEO turned out and the board looking for a buyer. Release | Follow @JohnCFierce
@RyanMFierce: What Facebook and Google billionaires could do for overlooked biotech brains. Item | Follow @RyanMFierce
> Shionogi wins FDA approval on Osphena for painful sex. Story
> Vertex plots a race through PhIII for 'breakthrough' combo CF therapy. Report
> Jazz strikes up a $120M Concert Pharma collaboration on next-gen Xyrem. More
> Roche follows GSK in move to unlock its data vault on drugs. Article
Pharma News
@FiercePharma: Allergan settles Botox case in OK. Article | Follow @FiercePharma
@EricPFierce: AstraZeneca manager accused of getting home makeover at the company's cost. Sunroom, new kitchen, bathroom fixtures. Story | Follow @EricPFierce
> Hospira issues three recalls as it faces crucial FDA inspection. Item
> FDA halts pediatric study of Amgen's Sensipar after death. Story
> India may kill compulsory licensing based on price. More
Drug Delivery News
@MichaelGFierce: Sanofi's Genzyme hits target with muscular dystrophy RNA drug in mice. Article | Follow @MichaelGFierce
> Ocular Therapeutix submits cataract-surgery sealant for FDA approval. Story
> Synthetic protein tricks immune system for drug delivery, device safety. News
> SHL ups Taiwanese auto injector production by $40M. More